Insider Trading activities at Jazz Pharmaceuticals Plc (JAZZ)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jazz Pharmaceuticals Plc (JAZZ) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jazz Pharmaceuticals Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1232524.

Total stock buying since 2015: $24,695,433.
Total stock sales since 2015: $175,721,274.
Total stock option exercises since 2015: $23,063,639.


 1   2   3 
33 insiders reported insider trading activities at Jazz Pharmaceuticals Plc (JAZZ):
Insider trading activities of Wilson Karen J
Insider trading activities of Berns Paul L
Insider trading activities of Larkin Finbar
Insider trading activities of Riedel Norbert G
Insider trading activities of O'keefe Kenneth W
Insider trading activities of Young Matthew P.
Insider trading activities of Oriordan Anne
Insider trading activities of Mulligan Seamus
Insider trading activities of Gala Renee D
Insider trading activities of Cozadd Bruce C
Insider trading activities of Cook Jennifer E.
Insider trading activities of Smith Mark Douglas
Insider trading activities of Carr Patricia
Insider trading activities of Pearce Samantha
Insider trading activities of Mcsharry Heather Ann
Insider trading activities of Gray Peter
Insider trading activities of Enright Patrick G
Insider trading activities of Tobias Jeffrey K
Insider trading activities of Iannone Robert
Insider trading activities of Mcgill Iain
Insider trading activities of Treacy Paul
Insider trading activities of Hooper Suzanne Sawochka
Insider trading activities of Schnee Elmar
Insider trading activities of Sohn Catherine A.
Insider trading activities of Miller Michael Patrick
Insider trading activities of Patil Neena M
Insider trading activities of Tovey Christopher J.
Insider trading activities of Sablich Kim
Insider trading activities of Smith Karen L.
Insider trading activities of Johnson Philip L
Insider trading activities of Henderson Mary Elizabeth
Insider trading activities of Cox Russell J.
Insider trading activities of Winningham Rick E

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Jazz Pharmaceuticals Plc (JAZZ).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 101,621 $10,057,861 41,509 $5,600,607 4,813 $569,040
2024 12,000 $1,435,800 17,030 $1,972,531 0 $0
2023 0 $0 48,698 $6,931,426 12,830 $966,649
2022 0 $0 178,819 $26,449,201 175,375 $10,471,706
2021 0 $0 75,994 $11,710,301 31,752 $1,486,946
2020 50,000 $5,544,330 67,130 $9,668,125 56,264 $882,841
2019 0 $0 53,277 $7,548,736 8,333 $517,809
2018 50,000 $7,179,700 87,026 $14,370,940 27,425 $2,435,236
2017 0 $0 92,629 $13,736,901 82,862 $3,685,505
2016 3,745 $477,742 125,690 $16,966,269 0 $0
2015 0 $0 359,569 $60,766,237 43,113 $2,047,907

Table 2. Monthly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 6,000 $771,690 0 $0
2025-08 0 $0 1,000 $113,210 0 $0
2025-07 0 $0 1,000 $107,630 0 $0
2025-06 0 $0 1,000 $108,950 0 $0
2025-05 101,621 $10,057,861 1,500 $176,350 0 $0
2025-04 0 $0 1,500 $185,625 0 $0
2025-03 0 $0 17,123 $2,412,195 0 $0
2025-02 0 $0 10,886 $1,539,812 4,813 $569,040
2025-01 0 $0 1,500 $185,145 0 $0
2024-12 0 $0 2,053 $248,831 0 $0
2024-11 0 $0 4,700 $567,457 0 $0
2024-09 0 $0 1,410 $152,703 0 $0
2024-06 0 $0 163 $17,738 0 $0
2024-05 0 $0 5,000 $548,250 0 $0
2024-03 12,000 $1,435,800 3,704 $437,552 0 $0
2023-12 0 $0 834 $99,470 0 $0
2023-09 0 $0 1,500 $216,375 0 $0
2023-08 0 $0 12,813 $1,770,974 0 $0
2023-06 0 $0 1,726 $220,909 0 $0
2023-05 0 $0 6,000 $790,476 0 $0
2023-03 0 $0 13,701 $1,901,549 10,706 $734,181
2023-02 0 $0 1,531 $239,295 531 $58,117
2023-01 0 $0 10,593 $1,692,378 1,593 $174,351
2022-12 0 $0 4,558 $709,225 2,655 $290,585

Table 3. Detailed insider trading at Jazz Pharmaceuticals Plc (JAZZ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Cozadd Bruce C (Director) Sale 6,000 128.62 771,690
2025-08-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 113.21 113,210
2025-07-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 107.63 107,630
2025-06-03 Cozadd Bruce C (Chairman & CEO) Sale 500 110.00 55,000
2025-06-02 Cozadd Bruce C (Chairman & CEO) Sale 500 107.90 53,950
2025-05-12 Mulligan Seamus (Director) Buy 1,621 103.00 166,961
2025-05-09 Mulligan Seamus (Director) Buy 100,000 98.91 9,890,900
2025-05-02 Cozadd Bruce C (Chairman & CEO) Sale 500 120.00 60,000
2025-05-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 116.35 116,350
2025-04-01 Cozadd Bruce C (Chairman & CEO) Sale 1,500 123.75 185,625
2025-03-10 Carr Patricia (SVP, Chief Accounting Officer) Sale 1,140 137.81 157,103
2025-03-10 Iannone Robert (EVP, Global Head of R&D & CMO) Sale 2,403 138.41 332,604
2025-03-07 Iannone Robert (EVP, Global Head of R&D & CMO) Sale 7,080 139.10 984,863
2025-03-03 Cozadd Bruce C (Chairman & CEO) Sale 6,500 144.25 937,625
2025-02-28 Carr Patricia (SVP, Chief Accounting Officer) Sale 773 143.29 110,767
2025-02-27 Carr Patricia (SVP, Chief Accounting Officer) Sale 4,813 144.42 695,074
2025-02-27 Carr Patricia (SVP, Chief Accounting Officer) Option Ex 4,813 118.23 569,040
2025-02-27 Patil Neena M (EVP & Chief Legal Officer) Sale 3,800 144.87 550,506
2025-02-03 Cozadd Bruce C (Chairman & CEO) Sale 1,500 122.31 183,465
2025-01-02 Cozadd Bruce C (Chairman & CEO) Sale 1,500 123.43 185,145
2024-12-02 Carr Patricia (SVP, Chief Accounting Officer) Sale 53 122.49 6,491
2024-12-02 Cozadd Bruce C (Chairman & CEO) Sale 2,000 121.17 242,340
2024-11-08 Patil Neena M (EVP & Chief Legal Officer) Sale 3,700 123.41 456,617
2024-11-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 110.84 110,840
2024-09-06 Henderson Mary Elizabeth (SVP, Technical Operations) Sale 1,410 108.30 152,703
2024-06-07 Carr Patricia (SVP, Chief Accounting Officer) Sale 163 108.83 17,738
2024-05-03 Patil Neena M (EVP & Chief Legal Officer) Sale 5,000 109.65 548,250
2024-03-07 Carr Patricia (SVP, Chief Accounting Officer) Sale 1,768 116.98 206,820
2024-03-06 Carr Patricia (SVP, Chief Accounting Officer) Sale 1,936 119.18 230,732
2024-03-01 Johnson Philip L (EVP & Chief Financial Officer) Buy 12,000 119.65 1,435,800
2023-12-04 Smith Mark Douglas (Director) Sale 417 119.27 49,735
2023-12-04 Cook Jennifer E. (Director) Sale 417 119.27 49,735
2023-09-01 Patil Neena M (EVP & Chief Legal Officer) Sale 1,500 144.25 216,375
2023-08-29 Carr Patricia (SVP, Chief Accounting Officer) Sale 142 143.47 20,372
2023-08-14 Carr Patricia (SVP, Chief Accounting Officer) Sale 158 138.16 21,828
2023-08-14 Oriordan Anne (Director) Sale 1,241 138.16 171,454
2023-08-14 Smith Mark Douglas (Director) Sale 1,241 138.16 171,454
2023-08-14 Cook Jennifer E. (Director) Sale 1,241 138.16 171,454
2023-08-14 Gray Peter (Director) Sale 1,241 138.16 171,454
2023-08-14 Mcsharry Heather Ann (Director) Sale 1,344 138.16 185,685
2023-08-14 Sohn Catherine A. (Director) Sale 1,241 138.16 171,455
2023-08-14 O'keefe Kenneth W (Director) Sale 1,241 138.16 171,455
2023-08-14 Winningham Rick E (Director) Sale 1,241 138.16 171,454
2023-08-14 Enright Patrick G (Director) Sale 1,241 138.16 171,455
2023-08-14 Riedel Norbert G (Director) Sale 1,241 138.16 171,454
2023-06-07 Carr Patricia (SVP, Chief Accounting Officer) Sale 126 127.92 16,117
2023-06-01 Patil Neena M (EVP & Chief Legal Officer) Sale 1,600 128.00 204,792
2023-05-18 Gala Renee D (EVP & Chief Financial Officer) Sale 6,000 131.75 790,476
2023-03-15 Carr Patricia (SVP, Chief Accounting Officer) Sale 2,046 133.22 272,568
2023-03-08 Sablich Kim (EVP, GM of U.S., Commercial Ma) Sale 3,013 139.81 421,232
2023-03-07 Larkin Finbar (SVP, Technical Operations) Sale 2,075 140.76 292,081
2023-03-07 O'keefe Kenneth W (Director) Sale 2,690 138.39 372,266
2023-03-07 O'keefe Kenneth W (Director) Option Ex 4,500 81.76 367,920
2023-03-06 Larkin Finbar (SVP, Technical Operations) Sale 1,706 143.92 245,525
2023-03-06 Larkin Finbar (SVP, Technical Operations) Option Ex 1,706 58.72 100,176
2023-03-05 Carr Patricia (SVP, Chief Accounting Officer) Sale 1,148 140.76 161,593
2023-03-04 Mulligan Seamus (Director) Option Ex 4,500 59.13 266,085
2023-02-02 Pearce Samantha (SVP, Head of Europe & Internat) Sale 531 157.26 83,505
2023-02-02 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 531 109.45 58,117
2023-02-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 155.79 155,790
2023-01-03 Pearce Samantha (SVP, Head of Europe & Internat) Sale 1,062 159.59 169,484
2023-01-03 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 1,062 109.45 116,234
2023-01-03 Cozadd Bruce C (Chairman & CEO) Sale 6,000 159.79 958,768
2022-12-13 Pearce Samantha (SVP, Head of Europe & Internat) Sale 1,593 155.45 247,629
2022-12-13 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 1,593 109.45 174,351
2022-12-05 Carr Patricia (SVP, Chief Accounting Officer) Sale 63 152.06 9,579
2022-12-02 Smith Mark Douglas (Director) Sale 420 154.68 64,966
2022-12-02 Cook Jennifer E. (Director) Sale 420 154.68 64,965
2022-12-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 157.00 157,000
2022-11-22 Enright Patrick G (Director) Sale 6,974 150.65 1,050,647
2022-11-16 Patil Neena M (EVP & Chief Legal Officer) Sale 3,510 142.34 499,613
2022-11-14 Larkin Finbar (SVP, Technical Operations) Sale 197 149.33 29,418
2022-11-10 Pearce Samantha (SVP, Head of Europe & Internat) Sale 2,126 155.00 329,530
2022-11-10 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 2,126 109.45 232,690
2022-11-10 Cozadd Bruce C (Chairman & CEO) Sale 2,000 150.00 300,000
2022-10-03 Cozadd Bruce C (Chairman & CEO) Sale 45,185 135.00 6,100,020
2022-10-03 Cozadd Bruce C (Chairman & CEO) Option Ex 62,905 59.13 3,719,572
2022-09-07 Larkin Finbar (SVP, Technical Operations) Sale 63 150.00 9,450
2022-08-15 Carr Patricia (SVP, Chief Accounting Officer) Sale 2,142 158.57 339,667
2022-08-15 Carr Patricia (SVP, Chief Accounting Officer) Option Ex 2,000 113.10 226,200
2022-08-08 Oriordan Anne (Director) Sale 1,089 152.32 165,876
2022-08-08 Smith Mark Douglas (Director) Sale 1,089 152.32 165,879
2022-08-08 Cook Jennifer E. (Director) Sale 1,089 152.32 165,879
2022-08-08 Gray Peter (Director) Sale 1,179 152.32 179,587
2022-08-08 Mcsharry Heather Ann (Director) Sale 6,679 153.46 1,024,952
2022-08-08 Mcsharry Heather Ann (Director) Option Ex 8,000 55.28 442,240
2022-08-08 Sohn Catherine A. (Director) Sale 1,089 152.32 165,879
2022-08-08 O'keefe Kenneth W (Director) Sale 1,089 152.33 165,883
2022-08-08 Winningham Rick E (Director) Sale 1,089 152.32 165,879
2022-08-08 Enright Patrick G (Director) Sale 1,089 152.33 165,883
2022-08-08 Riedel Norbert G (Director) Sale 1,089 152.32 165,876
2022-08-05 Riedel Norbert G (Director) Sale 8,000 155.87 1,246,920
2022-08-05 Riedel Norbert G (Director) Option Ex 8,000 55.28 442,240
2022-08-04 Pearce Samantha (SVP, Head of Europe & Internat) Sale 531 155.00 82,305
2022-08-04 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 531 109.45 58,117
2022-08-01 Cozadd Bruce C (Chairman & CEO) Sale 7,301 154.55 1,128,354
2022-08-01 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 52.98 513,905
2022-07-12 Pearce Samantha (SVP, Head of Europe & Internat) Sale 532 155.00 82,460
2022-07-12 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 532 109.45 58,227
2022-07-05 Tovey Christopher J. (EVP, COO & Managing Director E) Sale 5,209 160.00 833,440
2022-07-05 Tovey Christopher J. (EVP, COO & Managing Director E) Option Ex 4,032 .02 80
2022-07-05 Cozadd Bruce C (Chairman & CEO) Sale 8,775 157.68 1,383,668
2022-07-05 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2022-06-27 Pearce Samantha (SVP, Head of Europe & Internat) Sale 8,508 155.00 1,318,740
2022-06-27 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 8,508 109.45 931,200
2022-06-08 Pearce Samantha (SVP, Head of Europe & Internat) Sale 8,487 155.00 1,315,485
2022-06-08 Pearce Samantha (SVP, Head of Europe & Internat) Option Ex 5,835 109.45 638,640
2022-06-07 Sablich Kim (EVP & GM, North America) Sale 2,441 150.51 367,407
2022-06-06 Patil Neena M (Chief Legal Officer (CLO)) Sale 1,000 152.15 152,150
2022-06-06 Sablich Kim (EVP & GM, North America) Sale 1,388 152.15 211,184
2022-06-02 Carr Patricia (SVP, Chief Accounting Officer) Sale 131 150.26 19,684
2022-06-02 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2022-06-01 Cozadd Bruce C (Chairman & CEO) Sale 6,362 147.62 939,158
2022-06-01 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2022-05-11 Carr Patricia (SVP, Chief Accounting Officer) Sale 722 147.51 106,505
2022-05-10 Carr Patricia (SVP, Chief Accounting Officer) Sale 273 144.18 39,360
2022-05-09 Larkin Finbar (SVP, Technical Operations) Sale 1,747 148.94 260,192
2022-05-09 Carr Patricia (SVP, Chief Accounting Officer) Sale 1,067 149.71 159,739
2022-05-09 Oriordan Anne (Director) Sale 466 149.71 69,762
2022-05-06 Patil Neena M (Chief Legal Officer) Sale 296 153.92 45,559
2022-05-02 Cozadd Bruce C (Chairman & CEO) Sale 7,260 157.13 1,140,749
2022-05-02 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2022-04-04 Cozadd Bruce C (Chairman & CEO) Sale 10,772 158.16 1,703,753
2022-04-04 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2022-03-17 Cozadd Bruce C (Chairman & CEO) Option Ex 1,288 59.13 76,159
2022-02-01 Cozadd Bruce C (Chairman & CEO) Sale 6,372 139.21 887,020
2022-02-01 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2022-01-03 Cozadd Bruce C (Chairman & CEO) Sale 5,791 128.08 741,699
2022-01-03 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2021-12-02 Smith Mark Douglas (Director) Sale 417 121.30 50,582
2021-12-02 Cook Jennifer E. (Director) Sale 417 121.30 50,582
2021-12-01 Cozadd Bruce C (Chairman & CEO) Sale 6,748 122.72 828,148
2021-12-01 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2021-11-12 Larkin Finbar (SVP, Technical Operations) Sale 197 135.79 26,750
2021-11-11 Sablich Kim (EVP & GM, North America) Sale 2,748 135.01 370,999
2021-11-01 Cozadd Bruce C (Chairman & CEO) Sale 6,556 134.64 882,712
2021-11-01 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2021-10-04 Cozadd Bruce C (Chairman & CEO) Sale 6,598 129.87 856,902
2021-10-04 Cozadd Bruce C (Chairman & CEO) Option Ex 9,700 46.83 454,251
2021-09-08 Larkin Finbar (SVP, Technical Operations) Sale 63 134.51 8,474
2021-09-01 Cozadd Bruce C (Chairman & CEO) Sale 500 131.58 65,790
2021-08-06 Carr Patricia (SVP, Finance & PAO) Sale 157 147.96 23,229
2021-08-06 Gray Peter (Director) Sale 1,414 147.96 209,215
2021-08-06 Mcsharry Heather Ann (Director) Sale 1,414 147.96 209,215
2021-08-06 Sohn Catherine A. (Director) Sale 1,306 147.96 193,235
2021-08-06 O'keefe Kenneth W (Director) Sale 1,306 147.96 193,235
2021-08-06 Winningham Rick E (Director) Sale 1,306 147.96 193,235
2021-08-06 Riedel Norbert G (Director) Sale 1,306 147.96 193,235
2021-08-05 Schnee Elmar (Director) Sale 1,632 154.00 251,328
2021-08-05 Berns Paul L (Director) Sale 1,450 154.00 223,300
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of JAZZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jazz Pharmaceuticals Plc (symbol JAZZ, CIK number 1232524) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.